Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
3
×
detroit blog main
3
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
3
×
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
fda
immunotherapy
national
abeona therapeutics
accent therapeutics
achilles therapeutics
aimmune therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
allergy
alnylam pharmaceuticals
What
drug
3
×
fda
market
patients
advantages
agency
aimmune
allergy
approval
approved
awarded
bar
bio
brings
cancer
developed
eisai
expect
flags
friday
gamble
higher
immunotherapy
incidence
late
lorcaserin
loss
marketing
medco’s
medicine
mover
new
oral
payers
peanut
physicians
plan
post
pricing
pulls
Language
unset
3
×
Current search:
drug
×
unset
×
" san francisco blog main "
×
" detroit blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
